Abstract
Objective: To evaluate the efficacy of intralesional Triamcinolone Acetonide (TA) injection and incision and curettage (I&C) and their complications in chalazia.
 Study design: Quasi-experimental study.
 Place and duration: Combined Military Hospital Multan Pakistan, from May to Nov 2019.
 Methodology: We selected individuals with primary chalazion having a size of 2mm or more, with a duration of at least one month and not resolving with conservative treatment. Our sample was divided into two groups. Group-A was given a 5mg/ml Triamcinolone injection under aseptic conditions, and the group-B had incision and curettage.
 Results: The overall frequency of lesion in the upper lid 53 (66%) was more than in the lower lid 27 (34%), p=0.004. The complete resolution of the lesions after the repetition of the procedure was found to be almost the same in the two groups. In comparison, the resolution duration was longer in group-A versus group-B. The complications were more in the surgical group 6 (p=0.001) than in the Triamcinolone Acetonide group 11, (p=0.004).Conclusion: Our study signifies that intralesional Triamcinolone Acetonide injection is a safe procedure, having fewer complications. For individuals with poor compliance with conservative management, Triamcinolone Acetonide injections provide an alternative with an almost equal success rate and minimal complication.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
